Overview

A Safety and PK Study of IV Eravacycline

Status:
Unknown status
Trial end date:
2020-11-17
Target enrollment:
Participant gender:
Summary
This is a Phase 1, open-label, multi-center study to determine the pharmacokinetics and safety of intravenous Eravacycline in Children with Suspected or Confirmed Bacterial Infection. Male and Female subjects from 8 to <18 years of age who fulfill the inclusion/exclusion criteria will be enrolled in this study.
Phase:
Phase 1
Details
Lead Sponsor:
Tetraphase Pharmaceuticals, Inc.